Literature DB >> 29142358

Transitional Cell Carcinoma of Urinary Bladder Manifesting as Extensive Retroperitoneal and Axillary Lymph Node Metastasis: An Extremely Rare Case Scenario Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography Scan.

Abhishek Purkayastha1, Neelam Sharma1, Rekha Vashisth1, Braj Kishore2.   

Abstract

Transitional cell carcinoma (TCC) urinary bladder is known to metastasize to regional lymph nodes (LNs), liver, lung, bone, adrenal glands, and intestine. However, an asymptomatic TCC bladder manifesting as metastatic axillary LN mass and extensive retroperitoneal lymphadenopathy is rarely heard of. A 46-year-old male, smoker, presented with 8 cm × 6 cm right axillary swelling of 1-month duration. Aspiration cytology revealed metastatic deposits of poorly differentiated carcinoma favoring TCC. Metastatic evaluation with 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) scan showed mass lesion urinary bladder, conglomerate right axillary mass and extensive retroperitoneal LNs with significant metabolic activity, biopsy from which revealed deposits of TCC. Transurethral-resection of bladder confirmed TCC and was exhibited palliative chemotherapy on which he progressed. Received palliative radiotherapy to axilla to which he showed significant symptomatic clinical response. He developed obstructive uropathy and was kept on supportive care. Review of literature reveals that our case may be the second case of TCC bladder with generalized lymphadenopathy and the first case of asymptomatic bladder carcinoma manifesting with upfront disseminated abdominopelvic lymphadenopathy detected by 18FDG-PET scan ever reported in world literature.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography scan; generalized lymphadenopathy; metastasis; transitional cell carcinoma; urinary bladder

Year:  2017        PMID: 29142358      PMCID: PMC5672762          DOI: 10.4103/ijnm.IJNM_52_17

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


  9 in total

Review 1.  Current concepts in lymph node imaging.

Authors:  Maha Torabi; Suzanne L Aquino; Mukesh G Harisinghani
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

2.  A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09.

Authors:  G M Duchesne; J J Bolger; G O Griffiths; J Trevor Roberts; J D Graham; P J Hoskin; S D Fossâ; B M Uscinska; M K Parmar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  M J Moore; E W Winquist; N Murray; I F Tannock; S Huan; K Bennett; W Walsh; L Seymour
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients.

Authors:  A Wallmeroth; U Wagner; H Moch; T C Gasser; G Sauter; M J Mihatsch
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

6.  The relation between p53 overexpression and lymph node metastases in clinical stage t2 and t3a transitional cell bladder carcinoma.

Authors:  M C Uygur; I Yaman; L Kutluay; U Altuğ; D Erol
Journal:  J Exp Clin Cancer Res       Date:  1999-09

7.  Metastases from transitional cell carcinoma of urinary bladder.

Authors:  R J Babaian; D E Johnson; L Llamas; A G Ayala
Journal:  Urology       Date:  1980-08       Impact factor: 2.649

8.  Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy.

Authors:  Ashok K Hemal; Anurag Khaitan; Amit K Dinda; Narmada P Gupta; Amlesh Seth; P N Dogra; Gulam Nabi
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

9.  Transitional Cell Carcinoma of the Bladder Manifestating as Malignant Lymphoma with Generalized Lymphadenopathy.

Authors:  Venkat Pavan Kancharla; Frederick A Gulmi; Aref Agheli; Michael Degen; Arash Gohari; Ming Jiang; J C Wang
Journal:  Case Rep Oncol       Date:  2010-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.